PharmaCyte Biotech Inc (PMCB)

[Jimmy Joe]

Actually when one thinks about it this is a very small step for Nuvilex. The "big step" was already taken previously with Dr. Lohr.
Now it's time to replicate results from the first studies. Possibly to tweek those studies into giving even better results than the first studies under Dr. Lohr.

Those running the studies now know more about CiaB than they did the first time around. The inital sets of data and way in which they went about this study is a template toward better understanding of what may need to be done to enhance results.

50% of the battle has already been fought with the initial studies leading up to the first Phase 2B clinical under Dr Lohr.

Now comes the easier part. Somethings they already know how to address. I'm sure there are those things in the studies they may be trying to address for the first time such as excessive abdominal fluids as a result of the cancer.

The other 50% of the battle is almost underway.

If one has been in this stock for years things have never looked so good. Hang in there. In my opinion this could make those years of waiting....... worth every second.

By this time next year "all things will pass" as the late George Harrison wrote. A year goes by so fast. Patience......